New lung cancer find paves way for better therapies
A team of researchers has successfully inhibited tumour growth in a new subtype of lung cancer. (Getty Images) A team of researchers has successfully inhibited tumour growth in a new subtype of lung cancer. Adenocarcinomas, a non-small cell lung cancer (NSCLC), account for about 40 percent of cancer diagnoses, but few treatments are available for the disease. The team led by Elena Levantini of Beth Israel Deaconess Medical Center (BIDMC) identified a subtype of human adenocarcinoma. The research could help determine which individuals are at greatest risk of developing lung…
Read More